United States 119th Congress Status: In Committee 25 D cosponsors

HR 9699 — Drug Deal Disclosure Act

Last action — Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the House. Introduced July 15, 2026. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the House.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Stalled 26% · moderate confidence

  • In Committee

    Current position in the legislative process.

  • 25 sponsors

    1 primary, 24 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (25 D).

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

In plain language

The bill requires disclosures related to drug pricing and transactions.

This bill mandates transparency in drug pricing by requiring disclosures about drug transactions. It aims to provide consumers and policymakers with clearer information to make informed choices.

What this means for you
  • Consumers: This means you may have better access to information regarding drug prices, helping you make informed choices.

Bill Text

Action History

  1. Introduced in House

  2. Introduced in House

  3. Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  4. Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  5. Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 24 co-sponsors · 522 not signed on

Sponsors (1)

Co-sponsors (24)

Not signed on (522)

522 members have not signed on to this bill.

Show all 522 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors HR 9699?
HR 9699 is sponsored by Chu, Judy (Democratic), Castor, Kathy (Democratic), Lee, Summer L. (Democratic), Pappas, Chris (Democratic), Beyer, Donald S. (Democratic), Clarke, Yvette D. (Democratic), DelBene, Suzan K. (Democratic), Carson, André (Democratic), Dexter, Maxine (Democratic), Doggett, Lloyd (Democratic), Evans, Dwight (Democratic), Goodlander, Maggie (Democratic), Matsui, Doris O. (Democratic), McCollum, Betty (Democratic), Moore, Gwen (Democratic), Mfume, Kweisi (Democratic), Norton, Eleanor Holmes (Democratic), Panetta, Jimmy (Democratic), Ross, Deborah K. (Democratic), Schakowsky, Janice D. (Democratic), Schneider, Bradley Scott (Democratic), Takano, Mark (Democratic), Tlaib, Rashida (Democratic), Williams, Nikema (Democratic), and Tonko, Paul (Democratic).
What is the current status of HR 9699?
This bill is in committee in the House. Introduced July 15, 2026. It must pass committee before a floor vote.
Where can I track HR 9699?
Track HR 9699 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HR 9699

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HR 9699

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →